Twist Bioscience Corp

NASDAQ: TWST
$43.20
+$1.80 (+4.3%)
Closing price May 9, 2024

TWST Chart and Intraday Price

TWST Company Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address 455 MISSION BAY BOULEVARD SOUTH, SUITE 5, SAN FRANCISCO, CA, US
Fiscal Year End September
Latest Quarter 12/31/2023
Market Cap 2,248.54M USD
Shares Outstanding 57,818,000
Twist Bioscience Corp is at the forefront of synthetic DNA technology, offering a wide range of products and services. These include synthetic genes, gene fragments, and immunoglobulin G proteins for various sectors like therapeutics, diagnostics, and agriculture. The company also specializes in next-generation sequencing (NGS) tools, methylation detection kits, and DNA-based data storage solutions. Additionally, Twist Bioscience provides vital resources for drug discovery and development, including precision DNA libraries and antibody optimization solutions. Founded in 2013, its headquarters are in South San Francisco, California, marking it as a key player in biotech innovation.

TWST Articles

Wednesday's Top Analyst Upgrades and Downgrades: Amazon, AMC, Apple, CVS, Etsy, Goldman Sachs, PayPal, Tesla, T-Mobile and More
Wednesday's top analyst upgrades and downgrades included Amazon, AMC Entertainment, Apollo Global Management, Apple, Block, Capital One Financial, Carlyle, CVS Health, Etsy, Fox, Gilead Sciences,...
Chris Lange
Published:

Tuesday's Top Analyst Upgrades and Downgrades: Carvana, CSX, FedEx, Fox, Marathon, Petro China, Planet Fitness, Regeneron and More
Tuesday’s top analyst upgrades and downgrades included Coursera, CSX, Carvana, FedEx, Fox, Marathon, Petro China, Planet Fitness, Regeneron and Rackspace.
Chris Lange
Published: